Watchlist Price Alert

ENDRA Life Sciences Inc. (NDRA)

NASDAQ: NDRA · Real-Time Price · USD

3.28

-0.11 (-3.24%)

At close: Jun 17, 2025, 3:59 PM

3.40

3.66%

After-hours: Jun 17, 2025, 06:45 PM EDT

-3.24% (1D)

Bid	3.1
Market Cap	2.42M
Revenue (ttm)	211.6K
Net Income (ttm)	-9.77M
EPS (ttm)	390.78
PE Ratio (ttm)	0.01
Forward PE	-0.35
Analyst	Buy

Ask	3.49
Volume	18,004
Avg. Volume (20D)	173,463
Open	3.37
Previous Close	3.39
Day's Range	3.26 - 3.38
52-Week Range	2.90 - 271.25
Beta	-0.22

About NDRA

undefined

[Read more]

Industry n/a

Sector n/a

IPO Date n/a

Employees NaN

Stock Exchange n/a

Ticker Symbol NDRA

Website n/a

Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for NDRA stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts

Why Price Moved

7 months ago

-14.18%

ENDRA Life Sciences shares are trading lower. The ... Unlock content with Pro Subscription

7 months ago

+89.02%

ENDRA Life Sciences shares are trading higher after the company announced the activation of a post market clinical study of the TAEUS liver system.

News

1 day ago · businesswire.com

ENDRA's Ongoing Multisite Pilot Study Reveals Important Enhancements to Boost TAEUS Liver Accuracy and Repeatability Against MRI Gold Standard

ANN ARBOR, Mich.--(BUSINESS WIRE)--ENDRA Life Sciences Inc. (NASDAQ: NDRA), a pioneer in imaging technologies for the early detection and monitoring of metabolic liver disease, today announced that it...

2 months ago · businesswire.com

ENDRA Life Sciences Announces Enhanced Strategy to Enable the Early Detection and Management of Metabolic Diseases Facilitated by Emerging GLP-1 Therapies

ANN ARBOR, Mich.--(BUSINESS WIRE)--ENDRA Life Sciences Inc. (NASDAQ: NDRA), a pioneer of Thermo-Acoustic Enhanced UltraSound (TAEUS®), today announced a new strategic direction to develop and deploy i...